New patient focused cancer therapies

Event Details

The focus of the symposium will be on Immuno-Oncology with the following international speakers.
Inger Andersson, Chairman of IVA’s Biotechnology – Introduction

Professor Kjell Strandberg, former DG MPA – What is immune oncology?

Magnus Jäderberg, CMO Targovax, London – The new cancer drugs in a clinical perspective

Professor Peter Nygren, Department of Oncology, University Hospital, Uppsala – Faster approvals of new drugs against cancer?

Tomas Salmonson, Chairman of the EU drugs Board (CHMP)

Bertil Jonsson, Chairman CHMP Oncology Working Party, the European Medicines Agency (EMA) London – Price, value and payment

Professor Bengt Jönsson, Stockholm School of equal access for patients to new medicines?

Mats Eriksson, Chairman of the Regional Board Region Halland – Panel Discussion Moderator

Bjorn Odlander, Managing Partner Health


Please be aware that it is required to register before 12th May at the following website.


Fore more information see here.


Print This Post